Abstract
Upon binding, ligands can chaperone their protein targets by preventing them from misfolding and aggregating. Thus, an organic molecule that works as folding chaperone for a protein might be its specific ligand, and, similarly, the chaperone potential could represent an alternative readout in a molecular screening campaign toward the identification of new hits. Here we show that small molecules selected for acting as pharmacological chaperones on a misfolded mutant of the Frizzled4 (Fz4) receptor bind and modulate wild-type Fz4, representing what are to our knowledge the first organic ligands of this until-now-undruggable GPCR. The novelty and the advantages of the screening platform, the allosteric binding site addressed by these new ligands and the mechanism they use to modulate Fz4 suggest new avenues for development of inhibitors of the Wnt–β-catenin pathway and for drug discovery.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dobson, C.M. Protein folding and misfolding. Nature 426, 884–890 (2003).
Hartl, F.U. Chaperone-assisted protein folding: the path to discovery from a personal perspective. Nat. Med. 17, 1206–1210 (2011).
Hartl, F.U., Bracher, A. & Hayer-Hartl, M. Molecular chaperones in protein folding and proteostasis. Nature 475, 324–332 (2011).
Sitia, R. & Braakman, I. Quality control in the endoplasmic reticulum protein factory. Nature 426, 891–894 (2003).
Morello, J.P. et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J. Clin. Invest. 105, 887–895 (2000).
Tapper, A.R. et al. Nicotine activation of alpha4 receptors: sufficient for reward, tolerance, and sensitization. Science 306, 1029–1032 (2004).
Sallette, J. et al. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron 46, 595–607 (2005).
Xiao, C. et al. Chronic nicotine selectively enhances α4β2 nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J. Neurosci. 29, 12428–12439 (2009).
Eshaq, R.S. et al. GABA acts as a ligand chaperone in the early secretory pathway to promote cell surface expression of GABAA receptors. Brain Res. 1346, 1–13 (2010).
Halaban, R., Cheng, E., Svedine, S., Aron, R. & Hebert, D.N. Proper folding and endoplasmic reticulum to Golgi transport of tyrosinase are induced by its substrates, DOPA and tyrosine. J. Biol. Chem. 276, 11933–11938 (2001).
Schubert, U. et al. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404, 770–774 (2000).
Morello, J.P. & Bichet, D.G. Nephrogenic diabetes insipidus. Annu. Rev. Physiol. 63, 607–630 (2001).
Ulloa-Aguirre, A. & Michael Conn, P. Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein–coupled receptors. Recent Pat. Endocr. Metab. Immune Drug Discov. 5, 13–24 (2011).
Maya-Núñez, G., Ulloa-Aguirre, A., Janovick, J.A. & Conn, P.M. Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target. Subcell. Biochem. 63, 263–289 (2012).
Petäjä-Repo, U.E. et al. Ligands act as pharmacological chaperones and increase the efficiency of Δ opioid receptor maturation. EMBO J. 21, 1628–1637 (2002).
Newton, C.L. et al. Rescue of expression and signaling of human luteinizing hormone G protein–coupled receptor mutants with an allosterically binding small-molecule agonist. Proc. Natl. Acad. Sci. USA 108, 7172–7176 (2011).
Kobayashi, H., Ogawa, K., Yao, R., Lichtarge, O. & Bouvier, M. Functional rescue of beta-adrenoceptor dimerization and trafficking by pharmacological chaperones. Traffic 10, 1019–1033 (2009).
Bernier, V. et al. Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J. Am. Soc. Nephrol. 17, 232–243 (2006); erratum 17, 591 (2006).
Schulte, G. International union of basic and clinical pharmacology. LXXX. The class Frizzled receptors. Pharmacol. Rev. 62, 632–667 (2010).
Wang, H.Y., Liu, T. & Malbon, C.C. Structure-function analysis of Frizzleds. Cell. Signal. 18, 934–941 (2006).
Wang, Y. et al. Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity. Cell 151, 1332–1344 (2012).
Wong, H.C. et al. Structural basis of the recognition of the dishevelled DEP domain in the Wnt signaling pathway. Nat. Struct. Biol. 7, 1178–1184 (2000).
Strutt, D., Madder, D., Chaudhary, V. & Artymiuk, P.J. Structure-function dissection of the frizzled receptor in Drosophila melanogaster suggests different mechanisms of action in planar polarity and canonical Wnt signaling. Genetics 192, 1295–1313 (2012).
Kaykas, A. et al. Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization. Nat. Cell Biol. 6, 52–58 (2004).
Robitaille, J. et al. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat. Genet. 32, 326–330 (2002).
D'Agostino, M. et al. The cytosolic chaperone α-crystallin B rescues folding and compartmentalization of misfolded multispan transmembrane proteins. J. Cell Sci. 126, 4160–4172 (2013).
Lemma, V. et al. A disorder-to-order structural transition in the COOH-tail of Fz4 determines misfolding of the L501fsX533-Fz4 mutant. Sci. Rep. 3, 2659 (2013).
Malaterre, J., Ramsay, R.G. & Mantamadiotis, T. Wnt-Frizzled signaling and the many paths to neural development and adult brain homeostasis. Front. Biosci. 12, 492–506 (2007).
Jin, X. et al. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res. 71, 3066–3075 (2011).
Polakis, P. Drugging Wnt signaling in cancer. EMBO J. 31, 2737–2746 (2012).
Voronkov, A. & Krauss, S. Wnt/β-catenin signaling and small molecule inhibitors. Curr. Pharm. Des. 19, 634–664 (2013).
Schulte, G. & Bryja, V. The Frizzled family of unconventional G-protein–coupled receptors. Trends Pharmacol. Sci. 28, 518–525 (2007).
Zimmerman, Z.F., Moon, R.T. & Chien, A.J. Targeting Wnt pathways in disease. Cold Spring Harb. Perspect. Biol. 4, a008086 (2012).
Dann, C.E. et al. Insights into Wnt binding and signaling from the structures of two Frizzled cysteine-rich domains. Nature 412, 86–90 (2001).
MacDonald, B.T. & He, X. Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling. Cold Spring Harb. Perspect. Biol. 4, a007880 (2012).
Varga, K. et al. Enhanced cell surface stability of rescued ΔF508 cystic fibrosis transmembrane conductance regulator by pharmacological chaperones. Biochem. J. 410, 555–564 (2008).
Ke, J. et al. Structure and function of Norrin in assembly and activation of a Frizzled 4–Lrp5/6 complex. Genes Dev. 27, 2305–2319 (2013).
Tauriello, D.V. et al. Wnt/β-catenin signaling requires interaction of the Dishevelled DEP domain and C terminus with a discontinuous motif in Frizzled. Proc. Natl. Acad. Sci. USA 109, E812–E820 (2012).
D'Agostino, M. et al. ER reorganization is remarkably induced in COS-7 cells accumulating transmembrane protein receptors not competent for export from the endoplasmic reticulum. J. Membr. Biol. 247, 1149–1159 (2014).
Ekkebus, R. et al. On terminal alkynes that can react with active-site cysteine nucleophiles in proteases. J. Am. Chem. Soc. 135, 2867–2870 (2013).
Wang, C. et al. Structure of the human smoothened receptor bound to an antitumour agent. Nature 497, 338–343 (2013).
Ueno, K. et al. Frizzled-7 as a potential therapeutic target in colorectal cancer. Neoplasia 10, 697–705 (2008).
Chatel, G. et al. Hedgehog signaling pathway is inactive in colorectal cancer cell lines. Int. J. Cancer 121, 2622–2627 (2007).
Jung, H. et al. Deubiquitination of Dishevelled by Usp14 is required for Wnt signaling. Oncogenesis 2, E64 1–11 (2013).
Maher, M.T., Mo, R., Flozak, A.S., Peled, O.N. & Gottardi, C.J. β-Catenin phosphorylated at serine 45 is spatially uncoupled from β-catenin phosphorylated in the GSK3 domain: implications for signaling. PLoS ONE 5, e10184 (2010).
Jones, K.H., Liu, J. & Adler, P.N. Molecular analysis of EMS-induced frizzled mutations in Drosophila melanogaster. Genetics 142, 205–215 (1996).
Wu, X. et al. Rac1 activation controls nuclear localization of β-catenin during canonical Wnt signaling. Cell 133, 340–353 (2008).
Gurney, A. et al. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc. Natl. Acad. Sci. USA 109, 11717–11722 (2012).
Grandy, D. et al. Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled. J. Biol. Chem. 284, 16256–16263 (2009).
Radner, S. et al. Transient transfection coupled to baculovirus infection for rapid protein expression screening in insect cells. J. Struct. Biol. 179, 46–55 (2012).
Lommen, A. MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing. Anal. Chem. 81, 3079–3086 (2009).
Perkins, D.N. et al. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551–3567 (1999).
Winn, M.D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235–242 (2011).
Janda, C.Y., Waghray, D., Levin, A.M., Thomas, C. & Garcia, K.C. Structural basis of Wnt recognition by Frizzled. Science 337, 59–64 (2012).
Wang, C. et al. Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs. Nat. Commun. 5, 4355–4365 (2014).
Stornaiuolo, M. et al. Assembly of a π-π stack of ligands in the binding site of an acetylcholine-binding protein. Nat. Commun. 4, 1875 (2013).
Acknowledgements
We thank R. Polishchuk (Telethon Institute of Genetics and Medicine) and B.A. Stanton (Dartmouth Center for the Environmental Health Sciences) for sharing ATP-7B and CFTR expression constructs. We thank J. Hausmann for the fruitful discussions. We thank R. Carmelo for the technical help and A. Ciogli and A. Sansone for MS spectral analyses. This work was financed by Progetti di Rilevante Interesse Nazionale (PRIN) 2012–2015 (grant no. 2012C5YJSK_003) to L.M., PRIN2010-2011 (grant no. 2010W7YRLZ_001) to R.S., Bando Futuro in Ricerca 2010 (grant no. RBFR10ZJQT) to G.L.R. and Fondazione Telethon (grant no. GGP14002) to S.B.
Author information
Authors and Affiliations
Contributions
S.F.G. and M.S. performed all of the experiments with the assistance of S.B. and M.M. for HDX, and S.D.M. for LC/MS. M.D. performed the experiments on CaCO-2 cells. D.S. performed confocal imaging. M.G., G.L.R., S.P., H.C., A.B. and L.M. collected and synthesized the compounds of the library and performed chemical characterization. M.S. planned the work and analyzed the results. M.S. wrote the manuscript with assistance from E.N., S.B. and R.S.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Results, Supplementary Figures 1–30 and Supplementary Tables 1–6. (PDF 8612 kb)
Supplementary Note
Supplementary Notes (PDF 1223 kb)
Rights and permissions
About this article
Cite this article
Generoso, S., Giustiniano, M., La Regina, G. et al. Pharmacological folding chaperones act as allosteric ligands of Frizzled4. Nat Chem Biol 11, 280–286 (2015). https://doi.org/10.1038/nchembio.1770
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1770
This article is cited by
-
Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
Nature Communications (2023)
-
Structural insight into small molecule action on Frizzleds
Nature Communications (2020)
-
In situ characterization of stem cells-like biomarkers in meningiomas
Cancer Cell International (2018)
-
A novel small molecule chaperone of rod opsin and its potential therapy for retinal degeneration
Nature Communications (2018)